Achieve Life Sciences(DE:SP4P)
€5.35-0.15 (-2.73%)
DE:SP4P
Achieve Life Sciences financials statements
€5.35
At close:-0.15 (-2.73%)
Achieve Life Sciences (SP4P) Income Statement
3 Followers
Achieve Life Sciences Income Statement
Last quarter (Q3 2026), Achieve Life Sciences's total revenue was $0.00. In Q3, Achieve Life Sciences's net income was $-12.11M. See Achieve Life Sciences’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -228.00K | $ -229.00K | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 54.65M | $ 38.84M | $ 27.25M | $ 40.80M | $ 33.09M | |
| Depreciation and Amortization | $ 228.00K | $ 229.00K | $ 228.00K | $ 236.00K | $ 250.00K |
| $ -53.60M | $ -37.42M | $ -26.73M | $ -40.33M | $ -32.90M | |
| $ -54.88M | $ -39.07M | $ -27.25M | $ -40.80M | $ -33.09M | |
| $ 232.00K | $ -758.00K | $ -2.56M | $ -1.55M | $ -58.00K | |
| $ -54.65M | $ -39.83M | $ -29.82M | $ -42.35M | $ -33.15M | |
| $ -54.65M | $ -39.83M | $ -29.82M | $ -42.35M | $ -33.15M | |
| Per Share Metrics | |||||
| Basic EPS | $ -1.25 | $ -1.24 | $ -1.50 | $ -3.95 | $ -4.05 |
| Diluted EPS | $ -1.25 | $ -1.24 | $ -1.50 | $ -3.95 | $ -4.05 |
| Weighted Average Shares Outstanding | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M |
| Weighted Average Shares Outstanding (Diluted) | 43.59M | 32.07M | 19.83M | 10.59M | 8.12M |
Currency in USD

